A groundbreaking artificial intelligence method offers a profound new capability in cardiovascular
The journey through pediatric cancer treatment is a formidable one, marked not only by rigorous
The ability to precisely visualize and manipulate molecular machinery inside living cells has long represented a monumental challenge in biological research, but a new fusion of artificial intelligence and protein engineering is rapidly turning this ambition into reality. The development of
A groundbreaking study published in the journal Genes has fundamentally altered the scientific landscape for hypermobile Ehlers-Danlos syndrome (hEDS), proposing that the condition’s origins are not rooted in a single genetic flaw but rather a complex accumulation of variants across three distinct
The burgeoning market for GLP-1 weight-loss medications created a gold rush for telehealth
With a deep background in biopharmaceutical research and development, Ivan Kairatov has a keen eye
The biopharmaceutical sector is entering a new era. After last year's market disruptions, the industry faces a harsh truth: scientific breakthroughs alone are no longer enough to keep ahead of the…
By 2030, the tissue-engineering market is projected to exceed $32.45 billion , reflecting a
The landscape of rare disease drug development is littered with clinical failures. For every
Major policy changes are colliding with the complex economics of drug development. For B2B
Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is
We are joined today by Ivan Kairatov, a biopharma expert whose groundbreaking research is rewriting our fundamental understanding of how we learn. For over a century, we've believed that repetition is the key to learning, but his work reveals that timing is the far more critical ingredient. Our
A comprehensive analysis of the burgeoning conflict over the regulation of artificial intelligence
A groundbreaking study has fundamentally altered the scientific understanding of prenatal exposure
